Jeffrey J. Kooijman

Statistics

Publications

Citations

209

H-Index

Active since

2016

Affiliations

Center for Translational Molecular Medicine(Current)

Jeffrey J. Kooijman is an author at Center for Translational Molecular Medicine specializing in molecular oncology, molecular tumor profiling, and pharmacology.

ORCID

Publications per year

2016–2024

Publications

Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors

Neil T. Conlon, Jeffrey J. Kooijman, Suzanne J.C. van Gerwen et al. · British Journal of Cancer · 2021 · 70 citations · Full text

Medicine, Oncology, Pharmacology +17

Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines

Gisele Nishiguchi, Lauren G. Mascibroda, Sarah M. Young et al. · Nature Communications · 2024 · 46 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +13

Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use between 2013 and 2017

Joost C.M. Uitdehaag, Jeffrey J. Kooijman, Jeroen A.D.M. de Roos et al. · Molecular Cancer Therapeutics · 2018 · 29 citations

Medicine, Oncology, Pharmacology +16

Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020

Jeffrey J. Kooijman, Wilhelmina E. van Riel, Jelle Dylus et al. · Frontiers in Oncology · 2022 · 21 citations · Full text

Medicine, Oncology, Pharmacology +16

Cell Panel Profiling Reveals Conserved Therapeutic Clusters and Differentiates the Mechanism of Action of Different PI3K/mTOR, Aurora Kinase and EZH2 Inhibitors

Joost C.M. Uitdehaag, Jeroen A.D.M. de Roos, Martine B.W. Prinsen et al. · Molecular Cancer Therapeutics · 2016 · 18 citations

Medicine, Medicinal Chemistry, Pharmacology +13

1–5 of 7